NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|1215457371|gb|OXB58586|]
View 

hypothetical protein ASZ78_003857 [Callipepla squamata]

Protein Classification

carboxypeptidase N/E family protein( domain architecture ID 10301783)

carboxypeptidase N/E family protein is an M14 family zinc carboxypeptidase that relies on its substrate specificity and subcellular compartmentalization to prevent inappropriate cleavages that would otherwise damage the cell; it contains an extra C-terminal domain which may assist in folding of the carboxypeptidase domain, regulate enzyme activity, or be involved in interactions with other proteins or with membranes

CATH:  3.40.630.10
EC:  3.4.17.-
Gene Ontology:  GO:0006508|GO:0004181|GO:0008270
MEROPS:  M14
PubMed:  7674922|10493853

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
Peptidase_M14_like super family cl11393
M14 family of metallocarboxypeptidases and related proteins; The M14 family of ...
47-458 0e+00

M14 family of metallocarboxypeptidases and related proteins; The M14 family of metallocarboxypeptidases (MCPs), also known as funnelins, are zinc-binding carboxypeptidases (CPs) which hydrolyze single, C-terminal amino acids from polypeptide chains, and have a recognition site for the free C-terminal carboxyl group, which is a key determinant of specificity. Two major subfamilies of the M14 family, defined based on sequence and structural homology, are the A/B and N/E subfamilies. Enzymes belonging to the A/B subfamily are normally synthesized as inactive precursors containing preceding signal peptide, followed by an N-terminal pro-region linked to the enzyme; these proenzymes are called procarboxypeptidases. The A/B enzymes can be further divided based on their substrate specificity; Carboxypeptidase A-like (CPA-like) enzymes favor hydrophobic residues while carboxypeptidase B-like (CPB-like) enzymes only cleave the basic residues lysine or arginine. The A forms have slightly different specificities, with Carboxypeptidase A1 (CPA1) preferring aliphatic and small aromatic residues, and CPA2 preferring the bulky aromatic side chains. Enzymes belonging to the N/E subfamily enzymes are not produced as inactive precursors and instead rely on their substrate specificity and subcellular compartmentalization to prevent inappropriate cleavage. They contain an extra C-terminal transthyretin-like domain, thought to be involved in folding or formation of oligomers. MCPs can also be classified based on their involvement in specific physiological processes; the pancreatic MCPs participate only in alimentary digestion and include carboxypeptidase A and B (A/B subfamily), while others, namely regulatory MCPs or the N/E subfamily, are involved in more selective reactions, mainly in non-digestive tissues and fluids, acting on blood coagulation/fibrinolysis, inflammation and local anaphylaxis, pro-hormone and neuropeptide processing, cellular response and others. Another MCP subfamily, is that of succinylglutamate desuccinylase /aspartoacylase, which hydrolyzes N-acetyl-L-aspartate (NAA), and deficiency in which is the established cause of Canavan disease. Another subfamily (referred to as subfamily C) includes an exceptional type of activity in the MCP family, that of dipeptidyl-peptidase activity of gamma-glutamyl-(L)-meso-diaminopimelate peptidase I which is involved in bacterial cell wall metabolism.


The actual alignment was detected with superfamily member cd03865:

Pssm-ID: 472171 [Multi-domain]  Cd Length: 319  Bit Score: 683.63  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371  47 YHRYAELREALVAVWLQCPAVSRIYTVGRSSEGRELLVIEVSDRPGEHEPGElkrdeewlcvtskstvdpsycmeevsll 126
Cdd:cd03865     1 YHRYPELREALVSVWLQCPAISRIYTVGRSFEGRELLVIEVSDNPGEHEPGE---------------------------- 52
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 127 fcgtiantpradmnnhtgvvvnalklkpgePEFKYVGNMHGNEAVGRELLIFLAQYLCNEYQKGNETIINLIHSTQYTNL 206
Cdd:cd03865    53 ------------------------------PEFKYVGNMHGNEAVGRELLIFLAQYLCNEYQKGNETIINLIHSTRIHIM 102
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 207 SaFMVKETVKLFIQQPdrraaknlralylmskrmspssgnnkvgfviklpGELKDWFVGRSNAQGIDLNRNFPDLDRIVY 286
Cdd:cd03865   103 P-SLNPDGFEKAASQP----------------------------------GELKDWFVGRSNAQGIDLNRNFPDLDRIVY 147
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 287 VNEKEGGPNNHLLKNMKKAVDQNPKLAPETKGVIHWIMDIPFVLSANLHGGDLVANYPYDETRSGSAHEYSSCPDDAIFQ 366
Cdd:cd03865   148 VNEKEGGPNNHLLKNMKKAVDQNTKLAPETKAVIHWIMDIPFVLSANLHGGDLVANYPYDETRSGSAHEYSSCPDDAIFQ 227
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 367 SLARSYSSLNPAMSDPNRPPCRKNDDDSSFVDGTTNGGAWYSVPGGMQDFNYLSSNCFEITVELSCEKFPPEETLKGYWE 446
Cdd:cd03865   228 SLARAYSSLNPAMSDPNRPPCRKNDDDSSFVDGTTNGGAWYSVPGGMQDFNYLSSNCFEITVELSCEKFPPEETLKGYWE 307
                         410
                  ....*....|..
gi 1215457371 447 DNKNSLINYIEQ 458
Cdd:cd03865   308 DNKNSLINYIEQ 319
Peptidase_M14NE-CP-C_like cd11308
Peptidase associated domain: C-terminal domain of M14 N/E carboxypeptidase; putative folding, ...
462-536 2.77e-40

Peptidase associated domain: C-terminal domain of M14 N/E carboxypeptidase; putative folding, regulation, or interaction domain; This domain is found C-terminal to the M14 carboxypeptidase (CP) N/E subfamily containing zinc-binding enzymes that hydrolyze single C-terminal amino acids from polypeptide chains, and have a recognition site for the free C-terminal carboxyl group, which is a key determinant of specificity. The N/E subfamily includes enzymatically active members (carboxypeptidase N, E, M, D, and Z), as well as non-active members (carboxypeptidase-like protein 1, -2, aortic CP-like protein, and adipocyte enhancer binding protein-1) which lack the critical active site and substrate-binding residues considered necessary for activity. The active N/E enzymes fulfill a variety of cellular functions, including prohormone processing, regulation of peptide hormone activity, alteration of protein-protein or protein-cell interactions and transcriptional regulation. For M14 CPs, it has been suggested that this domain may assist in folding of the CP domain, regulate enzyme activity, or be involved in interactions with other proteins or with membranes; for carboxypeptidase M, it may interact with the bradykinin 1 receptor at the cell surface. This domain may also be found in other peptidase families.


:

Pssm-ID: 200604 [Multi-domain]  Cd Length: 76  Bit Score: 140.74  E-value: 2.77e-40
                          10        20        30        40        50        60        70
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1215457371 462 GVKGFVKDLQGNPIANATISVEGISHDITSAKDGDYWRLLVPGNYKLTASAPGYLAITKKVAVPFSP-AVVVDFEL 536
Cdd:cd11308     1 GIKGFVTDATGNPIANATISVEGINHDVTTAKDGDYWRLLLPGTYNVTASAPGYQPVTKTVTVPNNFsATVVNFTL 76
 
Name Accession Description Interval E-value
M14_CPE cd03865
Peptidase M14 carboxypeptidase subfamily N/E-like; Carboxypeptidase E subgroup; Peptidase M14 ...
47-458 0e+00

Peptidase M14 carboxypeptidase subfamily N/E-like; Carboxypeptidase E subgroup; Peptidase M14 Carboxypeptidase (CP) E (CPE, also known as carboxypeptidase H, and enkephalin convertase; EC 3.4.17.10) belongs to the N/E subfamily of the M14 family of metallocarboxypeptidases (MCPs).The M14 family are zinc-binding CPs which hydrolyze single, C-terminal amino acids from polypeptide chains, and have a recognition site for the free C-terminal carboxyl group, which is a key determinant of specificity. CPE is an important enzyme responsible for the proteolytic processing of prohormone intermediates (such as pro-insulin, pro-opiomelanocortin, or pro-gonadotropin-releasing hormone) by specifically removing C-terminal basic residues. In addition, it has been proposed that the regulated secretory pathway (RSP) of the nervous and endocrine systems utilizes membrane-bound CPE as a sorting receptor. A naturally occurring point mutation in CPE reduces the stability of the enzyme and causes its degradation, leading to an accumulation of numerous neuroendocrine peptides that result in obesity and hyperglycemia. Reduced CPE enzyme and receptor activity could underlie abnormal placental phenotypes from the observation that CPE is down-regulated in enlarged placentas of interspecific hybrid (interspecies hybrid placental dysplasia, IHPD) and cloned mice.


Pssm-ID: 349437 [Multi-domain]  Cd Length: 319  Bit Score: 683.63  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371  47 YHRYAELREALVAVWLQCPAVSRIYTVGRSSEGRELLVIEVSDRPGEHEPGElkrdeewlcvtskstvdpsycmeevsll 126
Cdd:cd03865     1 YHRYPELREALVSVWLQCPAISRIYTVGRSFEGRELLVIEVSDNPGEHEPGE---------------------------- 52
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 127 fcgtiantpradmnnhtgvvvnalklkpgePEFKYVGNMHGNEAVGRELLIFLAQYLCNEYQKGNETIINLIHSTQYTNL 206
Cdd:cd03865    53 ------------------------------PEFKYVGNMHGNEAVGRELLIFLAQYLCNEYQKGNETIINLIHSTRIHIM 102
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 207 SaFMVKETVKLFIQQPdrraaknlralylmskrmspssgnnkvgfviklpGELKDWFVGRSNAQGIDLNRNFPDLDRIVY 286
Cdd:cd03865   103 P-SLNPDGFEKAASQP----------------------------------GELKDWFVGRSNAQGIDLNRNFPDLDRIVY 147
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 287 VNEKEGGPNNHLLKNMKKAVDQNPKLAPETKGVIHWIMDIPFVLSANLHGGDLVANYPYDETRSGSAHEYSSCPDDAIFQ 366
Cdd:cd03865   148 VNEKEGGPNNHLLKNMKKAVDQNTKLAPETKAVIHWIMDIPFVLSANLHGGDLVANYPYDETRSGSAHEYSSCPDDAIFQ 227
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 367 SLARSYSSLNPAMSDPNRPPCRKNDDDSSFVDGTTNGGAWYSVPGGMQDFNYLSSNCFEITVELSCEKFPPEETLKGYWE 446
Cdd:cd03865   228 SLARAYSSLNPAMSDPNRPPCRKNDDDSSFVDGTTNGGAWYSVPGGMQDFNYLSSNCFEITVELSCEKFPPEETLKGYWE 307
                         410
                  ....*....|..
gi 1215457371 447 DNKNSLINYIEQ 458
Cdd:cd03865   308 DNKNSLINYIEQ 319
Peptidase_M14 pfam00246
Zinc carboxypeptidase;
53-451 5.95e-64

Zinc carboxypeptidase;


Pssm-ID: 459730 [Multi-domain]  Cd Length: 287  Bit Score: 211.00  E-value: 5.95e-64
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371  53 LREALVAVWLQCPAVSRIYTVGRSSEGRELLVIEVSDRPGEHepgelkrdeewlcvtskstvdpsycmeevsllfcgtia 132
Cdd:pfam00246   1 IEAWLDALAARYPDLVRLVSIGKSVEGRPLKVLKISSGPGEH-------------------------------------- 42
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 133 ntpradmnnhtgvvvnalklKPGEPEFKYVGNMHGNEAVGRELLIFLAQYLCNEYQKgNETIINLIHSTqytnlsafmvk 212
Cdd:pfam00246  43 --------------------NPGKPAVFIDGGIHAREWIGPATALYLIHQLLTNYGR-DPEITELLDDT----------- 90
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 213 eTVKLFIQ-QPDrraaknlralylmskrmspssgnnkvGFVIKLPGElKDWFVGRSNAQ-----GIDLNRNFPDL----- 281
Cdd:pfam00246  91 -DIYILPVvNPD--------------------------GYEYTHTTD-RLWRKNRSNANgssciGVDLNRNFPDHwnevg 142
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 282 DRIVYVNEKEGGPNNHLlknmkkavdqnpklAPETKGVIHWIMD-IPFVLSANLHGGDLVANYPYDETRSgsaheySSCP 360
Cdd:pfam00246 143 ASSNPCSETYRGPAPFS--------------EPETRAVADFIRSkKPFVLYISLHSYSQVLLYPYGYTRD------EPPP 202
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 361 DDAIFQSLARSYSSLNPAMSDpnrppcrknddDSSFVDGTTNGGAWYSVPGGMQDFNYLSSNC-FEITVELSCEK----F 435
Cdd:pfam00246 203 DDEELKSLARAAAKALQKMVR-----------GTSYTYGITNGATIYPASGGSDDWAYGRLGIkYSYTIELRDTGrygfL 271
                         410
                  ....*....|....*.
gi 1215457371 436 PPEETLKGYWEDNKNS 451
Cdd:pfam00246 272 LPASQIIPTAEETWEA 287
Zn_pept smart00631
Zn_pept domain;
47-441 1.31e-43

Zn_pept domain;


Pssm-ID: 214748 [Multi-domain]  Cd Length: 277  Bit Score: 156.34  E-value: 1.31e-43
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371   47 YHRYAELREALVAVWLQCPAVSRIYTVGRSSEGRELLVIEVSDRPGehepgelkrdeewlcvtskstvdpsycmeevsll 126
Cdd:smart00631   1 YHSYEEIEAWLKELAARYPDLVRLVSIGKSVEGRPIWVLKISNGGS---------------------------------- 46
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371  127 fcgtiantpradmnnhtgvvvnalklkPGEPEFKYVGNMHGNEAVGRELLIFLAQYLCNEYQKgNETIINLIHSTQytnl 206
Cdd:smart00631  47 ---------------------------HDKPAIFIDAGIHAREWIGPATALYLINQLLENYGR-DPRVTNLLDKTD---- 94
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371  207 safmvketvklfiqqpdrraaknlraLYLMSkRMSPSsgnnkvGFVIKLPGElKDWFVGRS---NAQGIDLNRNFPDLdr 283
Cdd:smart00631  95 --------------------------IYIVP-VLNPD------GYEYTHTGD-RLWRKNRSpnsNCRGVDLNRNFPFH-- 138
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371  284 ivyvNEKEGGPNNHLLKNmkkavdQNPKLAPETKGVIHWIMD-IPFVLSANLHGGDLVANYPYDETRSGSAHEYSScpDD 362
Cdd:smart00631 139 ----WGETGNPCSETYAG------PSPFSEPETKAVRDFIRSnRRFKLYIDLHSYSQLILYPYGYTKNDLPPNVDD--LD 206
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371  363 AIFQSLARSYSSLNPamsdpnrppcrkndddSSFVDGTTNGGAWYsVPGGMQDFNYLSSN-CFEITVELSCE-----KFP 436
Cdd:smart00631 207 AVAKALAKALASVHG----------------TRYTYGISNGAIYP-ASGGSDDWAYGVLGiPFSFTLELRDDgrygfLLP 269

                   ....*
gi 1215457371  437 PEETL 441
Cdd:smart00631 270 PSQII 274
Peptidase_M14NE-CP-C_like cd11308
Peptidase associated domain: C-terminal domain of M14 N/E carboxypeptidase; putative folding, ...
462-536 2.77e-40

Peptidase associated domain: C-terminal domain of M14 N/E carboxypeptidase; putative folding, regulation, or interaction domain; This domain is found C-terminal to the M14 carboxypeptidase (CP) N/E subfamily containing zinc-binding enzymes that hydrolyze single C-terminal amino acids from polypeptide chains, and have a recognition site for the free C-terminal carboxyl group, which is a key determinant of specificity. The N/E subfamily includes enzymatically active members (carboxypeptidase N, E, M, D, and Z), as well as non-active members (carboxypeptidase-like protein 1, -2, aortic CP-like protein, and adipocyte enhancer binding protein-1) which lack the critical active site and substrate-binding residues considered necessary for activity. The active N/E enzymes fulfill a variety of cellular functions, including prohormone processing, regulation of peptide hormone activity, alteration of protein-protein or protein-cell interactions and transcriptional regulation. For M14 CPs, it has been suggested that this domain may assist in folding of the CP domain, regulate enzyme activity, or be involved in interactions with other proteins or with membranes; for carboxypeptidase M, it may interact with the bradykinin 1 receptor at the cell surface. This domain may also be found in other peptidase families.


Pssm-ID: 200604 [Multi-domain]  Cd Length: 76  Bit Score: 140.74  E-value: 2.77e-40
                          10        20        30        40        50        60        70
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1215457371 462 GVKGFVKDLQGNPIANATISVEGISHDITSAKDGDYWRLLVPGNYKLTASAPGYLAITKKVAVPFSP-AVVVDFEL 536
Cdd:cd11308     1 GIKGFVTDATGNPIANATISVEGINHDVTTAKDGDYWRLLLPGTYNVTASAPGYQPVTKTVTVPNNFsATVVNFTL 76
CarboxypepD_reg pfam13620
Carboxypeptidase regulatory-like domain;
462-536 5.58e-16

Carboxypeptidase regulatory-like domain;


Pssm-ID: 433354 [Multi-domain]  Cd Length: 81  Bit Score: 73.08  E-value: 5.58e-16
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 462 GVKGFVKDLQGNPIANATISVE----GISHDITSAKDGDYW-RLLVPGNYKLTASAPGYLAITKK-VAVPFSPAVVVDFE 535
Cdd:pfam13620   1 TISGTVTDPSGAPVPGATVTVTntdtGTVRTTTTDADGRYRfPGLPPGTYTVTVSAPGFKTATRTgVTVTAGQTTTLDVT 80

                  .
gi 1215457371 536 L 536
Cdd:pfam13620  81 L 81
MpaA COG2866
Murein tripeptide amidase MpaA [Cell wall/membrane/envelope biogenesis];
46-383 4.72e-08

Murein tripeptide amidase MpaA [Cell wall/membrane/envelope biogenesis];


Pssm-ID: 442113 [Multi-domain]  Cd Length: 337  Bit Score: 55.08  E-value: 4.72e-08
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371  46 EYHRYAELREALVAVWLQCPAVsRIYTVGRSSEGRELLVIEVSDRpgehepgelkrdeewlcvtskstvdpsycmeevsl 125
Cdd:COG2866    18 RYYTYEELLALLAKLAAASPLV-ELESIGKSVEGRPIYLLKIGDP----------------------------------- 61
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 126 lfcgtiantpradmnnhtgvvvnalklKPGEPEFKYVGNMHGNEAVGRELLIFLAQYLCneyqkgnetiinlihsTQYTN 205
Cdd:COG2866    62 ---------------------------AEGKPKVLLNAQQHGNEWTGTEALLGLLEDLL----------------DNYDP 98
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 206 LSAFMVKETVKLFIqqPdrraaknlralylmskRMSPSsgnnkvgfviklpGELKDWfvgRSNAQGIDLNRNFPDLDRiv 285
Cdd:COG2866    99 LIRALLDNVTLYIV--P----------------MLNPD-------------GAERNT---RTNANGVDLNRDWPAPWL-- 142
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 286 yvnekeggpnnhllknmkkavdqnpkLAPETKGVIHWIMDIPFVLSANLHGGDLVANYPYDETRSGSAHEYSSCPD--DA 363
Cdd:COG2866   143 --------------------------SEPETRALRDLLDEHDPDFVLDLHGQGELFYWFVGTTEPTGSFLAPSYDEerEA 196
                         330       340
                  ....*....|....*....|
gi 1215457371 364 IFQSLARSYSSLNPAMSDPN 383
Cdd:COG2866   197 FAEELNFEGIILAGSAFLGA 216
 
Name Accession Description Interval E-value
M14_CPE cd03865
Peptidase M14 carboxypeptidase subfamily N/E-like; Carboxypeptidase E subgroup; Peptidase M14 ...
47-458 0e+00

Peptidase M14 carboxypeptidase subfamily N/E-like; Carboxypeptidase E subgroup; Peptidase M14 Carboxypeptidase (CP) E (CPE, also known as carboxypeptidase H, and enkephalin convertase; EC 3.4.17.10) belongs to the N/E subfamily of the M14 family of metallocarboxypeptidases (MCPs).The M14 family are zinc-binding CPs which hydrolyze single, C-terminal amino acids from polypeptide chains, and have a recognition site for the free C-terminal carboxyl group, which is a key determinant of specificity. CPE is an important enzyme responsible for the proteolytic processing of prohormone intermediates (such as pro-insulin, pro-opiomelanocortin, or pro-gonadotropin-releasing hormone) by specifically removing C-terminal basic residues. In addition, it has been proposed that the regulated secretory pathway (RSP) of the nervous and endocrine systems utilizes membrane-bound CPE as a sorting receptor. A naturally occurring point mutation in CPE reduces the stability of the enzyme and causes its degradation, leading to an accumulation of numerous neuroendocrine peptides that result in obesity and hyperglycemia. Reduced CPE enzyme and receptor activity could underlie abnormal placental phenotypes from the observation that CPE is down-regulated in enlarged placentas of interspecific hybrid (interspecies hybrid placental dysplasia, IHPD) and cloned mice.


Pssm-ID: 349437 [Multi-domain]  Cd Length: 319  Bit Score: 683.63  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371  47 YHRYAELREALVAVWLQCPAVSRIYTVGRSSEGRELLVIEVSDRPGEHEPGElkrdeewlcvtskstvdpsycmeevsll 126
Cdd:cd03865     1 YHRYPELREALVSVWLQCPAISRIYTVGRSFEGRELLVIEVSDNPGEHEPGE---------------------------- 52
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 127 fcgtiantpradmnnhtgvvvnalklkpgePEFKYVGNMHGNEAVGRELLIFLAQYLCNEYQKGNETIINLIHSTQYTNL 206
Cdd:cd03865    53 ------------------------------PEFKYVGNMHGNEAVGRELLIFLAQYLCNEYQKGNETIINLIHSTRIHIM 102
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 207 SaFMVKETVKLFIQQPdrraaknlralylmskrmspssgnnkvgfviklpGELKDWFVGRSNAQGIDLNRNFPDLDRIVY 286
Cdd:cd03865   103 P-SLNPDGFEKAASQP----------------------------------GELKDWFVGRSNAQGIDLNRNFPDLDRIVY 147
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 287 VNEKEGGPNNHLLKNMKKAVDQNPKLAPETKGVIHWIMDIPFVLSANLHGGDLVANYPYDETRSGSAHEYSSCPDDAIFQ 366
Cdd:cd03865   148 VNEKEGGPNNHLLKNMKKAVDQNTKLAPETKAVIHWIMDIPFVLSANLHGGDLVANYPYDETRSGSAHEYSSCPDDAIFQ 227
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 367 SLARSYSSLNPAMSDPNRPPCRKNDDDSSFVDGTTNGGAWYSVPGGMQDFNYLSSNCFEITVELSCEKFPPEETLKGYWE 446
Cdd:cd03865   228 SLARAYSSLNPAMSDPNRPPCRKNDDDSSFVDGTTNGGAWYSVPGGMQDFNYLSSNCFEITVELSCEKFPPEETLKGYWE 307
                         410
                  ....*....|..
gi 1215457371 447 DNKNSLINYIEQ 458
Cdd:cd03865   308 DNKNSLINYIEQ 319
M14_CP_N-E_like cd03858
Peptidase M14 carboxypeptidase subfamily N/E-like; Carboxypeptidase (CP) N/E-like subfamily of ...
47-458 3.79e-152

Peptidase M14 carboxypeptidase subfamily N/E-like; Carboxypeptidase (CP) N/E-like subfamily of the M14 family of metallocarboxypeptidases (MCPs). The M14 family are zinc-binding CPs which hydrolyze single, C-terminal amino acids from polypeptide chains, and have a recognition site for the free C-terminal carboxyl group, which is a key determinant of specificity. The N/E subfamily includes eight members, of which five (CPN, CPE, CPM, CPD, CPZ) are considered enzymatically active, while the other three are non-active (CPX1, PCX2, ACLP/AEBP1) and lack the critical active site and substrate-binding residues considered necessary for CP activity. These non-active members may function as binding proteins or display catalytic activity towards other substrates. Unlike the A/B CP subfamily, enzymes belonging to the N/E subfamily are not produced as inactive precursors that require proteolysis to produce the active form; rather, they rely on their substrate specificity and subcellular compartmentalization to prevent inappropriate cleavages that would otherwise damage the cell. In addition, all members of the N/E subfamily contain an extra C-terminal domain that is not present in the A/B subfamily. This domain has structural homology to transthyretin and other proteins and has been proposed to function as a folding domain. The active N/E enzymes fulfill a variety of cellular functions, including prohormone processing, regulation of peptide hormone activity, alteration of protein-protein or protein-cell interactions and transcriptional regulation.


Pssm-ID: 349431 [Multi-domain]  Cd Length: 292  Bit Score: 437.85  E-value: 3.79e-152
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371  47 YHRYAELREALVAVWLQCPAVSRIYTVGRSSEGRELLVIEVSDRPGEHEPGElkrdeewlcvtskstvdpsycmeevsll 126
Cdd:cd03858     1 HHNYEELEEFLKQVAKRYPNITRLYSIGKSVEGRELWVLEISDNPGVHEPGE---------------------------- 52
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 127 fcgtiantpradmnnhtgvvvnalklkpgePEFKYVGNMHGNEAVGRELLIFLAQYLCNEYqKGNETIINLIHSTQytnl 206
Cdd:cd03858    53 ------------------------------PEFKYVANMHGNEVVGRELLLLLAEYLCENY-GKDPRVTQLVNSTR---- 97
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 207 safmvketvklfiqqpdrraaknlraLYLMskrmsPSSgnNKVGFVIKLPGElKDWFVGRSNAQGIDLNRNFPDLDRIVY 286
Cdd:cd03858    98 --------------------------IHIM-----PSM--NPDGYEKAQEGD-CGGLIGRNNANGVDLNRNFPDQFFQVY 143
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 287 vnekeggpnnhllknmkkavDQNPKLAPETKGVIHWIMDIPFVLSANLHGGDLVANYPYDETRSGSAHEYSSCPDDAIFQ 366
Cdd:cd03858   144 --------------------SDNNPRQPETKAVMNWLESIPFVLSANLHGGALVANYPYDDTRSGKSTEYSPSPDDAVFR 203
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 367 SLARSYSSLNPAMSDPNRPPCrknDDDSSFVDGTTNGGAWYSVPGGMQDFNYLSSNCFEITVELSCEKFPPEETLKGYWE 446
Cdd:cd03858   204 MLARSYSDAHPTMSMGKPCCC---DDDENFPNGITNGAAWYSVSGGMQDFNYLHTNCFEITLELGCCKYPPASELPKYWE 280
                         410
                  ....*....|..
gi 1215457371 447 DNKNSLINYIEQ 458
Cdd:cd03858   281 DNKRSLLNFLEQ 292
M14_CPN cd03864
Peptidase M14 carboxypeptidase subfamily N/E-like; Carboxypeptidase N subgroup; Peptidase M14 ...
47-458 1.83e-109

Peptidase M14 carboxypeptidase subfamily N/E-like; Carboxypeptidase N subgroup; Peptidase M14 Carboxypeptidase N (CPN, also known as kininase I, creatine kinase conversion factor, plasma carboxypeptidase B, arginine carboxypeptidase, and protaminase; EC 3.4.17.3) is an extracellular glycoprotein synthesized in the liver and released into the blood, where it is present in high concentrations. CPN belongs to the N/E subfamily of the M14 family of metallocarboxypeptidases (MCPs).The M14 family are zinc-binding carboxypeptidases (CPs) which hydrolyze single, C-terminal amino acids from polypeptide chains, and have a recognition site for the free C-terminal carboxyl group, which is a key determinant of specificity. CPN plays an important role in protecting the body from excessive buildup of potentially deleterious peptides that normally act as local autocrine or paracrine hormones. It specifically removes C-terminal basic residues. As CPN can cleave lysine more avidly than arginine residues it is also called lysine carboxypeptidase. CPN substrates include peptides found in the bloodstream, such as kinins (e.g. bradykinin, kalinin, met-lys-bradykinin), complement anaphylatoxins and creatine kinase MM (CK-MM). By removing just one amino acid, CPN can alter peptide activity and receptor binding. For example Bradykinin, a nine-residue peptide released from kiningen in response to tissue injury which is inactivated by CPN, anaphylatoxins which are regulated by CPN by the cleaving and removal of their C-terminal arginines resulting in a reduction in their biological activities of 10-100-fold, and creatine kinase MM, a cytosolic enzyme that catalyzes the reversible transfer of a phosphate group from ATP to creatine, and is regulated by CPN by the cleavage of C-terminal lysines. Like the other N/E subfamily members, two surface loops surrounding the active-site groove restrict access to the catalytic center, thus restricting larger protein carboxypeptidase inhibitors from inhibiting CPN.


Pssm-ID: 349436 [Multi-domain]  Cd Length: 313  Bit Score: 329.59  E-value: 1.83e-109
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371  47 YHRYAELREALVAVWLQCPAVSRIYTVGRSSEGRELLVIEVSDRPGEHEPGElkrdeewlcvtskstvdpsycmeevsll 126
Cdd:cd03864     1 HHRYDDLVRALYAVQNECPYITRIYSIGRSVEGRHLYVLEFSDNPGIHEPLE---------------------------- 52
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 127 fcgtiantpradmnnhtgvvvnalklkpgePEFKYVGNMHGNEAVGRELLIFLAQYLCNEYQKGNETIINLIHSTQYTNL 206
Cdd:cd03864    53 ------------------------------PEFKYVGNMHGNEVLGRELLIQLSEFLCEEYRNGNERITRLIQDTRIHIL 102
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 207 SAFmvketvklfiqQPDRraaknlralYLMSKRMSPSSgnnkvgfviklPGELkdwfVGRSNAQGIDLNRNFPDLDRIVY 286
Cdd:cd03864   103 PSM-----------NPDG---------YEVAARQGPEF-----------NGYL----VGRNNANGVDLNRNFPDLNTLMY 147
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 287 VNEKEGGPNNH--LLKNMKKAVDqnpklaPETKGVIHWIMDIPFVLSANLHGGDLVANYPYDET-----RSGSAHEYSSC 359
Cdd:cd03864   148 YNEKYGGPNHHlpLPDNWKSQVE------PETLAVIQWMQNYNFVLSANLHGGAVVANYPYDKSreprvRGFRRTAYSPT 221
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 360 PDDAIFQSLARSYSSLNPAMSdpnrppcRKNDDDSSFVDGTTNGGAWYSVPGGMQDFNYLSSNCFEITVELSCEKFPPEE 439
Cdd:cd03864   222 PDDKLFQKLAKTYSYAHGWMH-------KGWNCGDYFDEGITNGASWYSLSKGMQDFNYLHTNCFEITLELSCDKFPPEE 294
                         410
                  ....*....|....*....
gi 1215457371 440 TLKGYWEDNKNSLINYIEQ 458
Cdd:cd03864   295 ELEREWLGNREALISYMEQ 313
M14_CPD_I cd03868
Peptidase M14 carboxypeptidase subfamily N/E-like; Carboxypeptidase D, domain I subgroup; The ...
47-458 6.40e-106

Peptidase M14 carboxypeptidase subfamily N/E-like; Carboxypeptidase D, domain I subgroup; The first carboxypeptidase (CP)-like domain of Carboxypeptidase D (CPD; EC 3.4.17.22), domain I. CPD differs from all other metallocarboxypeptidases in that it contains multiple CP-like domains. CPD belongs to the N/E-like subfamily of the M14 family of metallocarboxypeptidases (MCPs).The M14 family are zinc-binding CPs which hydrolyze single, C-terminal amino acids from polypeptide chains, and have a recognition site for the free C-terminal carboxyl group, which is a key determinant of specificity. CPD is a single-chain protein containing a signal peptide, three tandem repeats of CP-like domains separated by short bridge regions, followed by a transmembrane domain, and a C-terminal cytosolic tail. The first two CP-like domains of CPD contain all of the essential active site and substrate-binding residues, the third CP-like domain lacks critical residues necessary for enzymatic activity and is inactive towards standard CP substrates. Domain I is optimally active at pH 6.3-7.5 and prefers substrates with C-terminal Arg, whereas domain II is active at pH 5.0-6.5 and prefers substrates with C-terminal Lys. This Domain I family contains two contiguous surface cysteines that may become palmitoylated and target the enzyme to membranes, thus regulating intracellular trafficking. CPD functions in the processing of proteins that transit the secretory pathway, and is present in all vertebrates as well as Drosophila. It is broadly distributed in all tissue types. Within cells, CPD is present in the trans Golgi network and immature secretory vesicles, but is excluded from mature vesicles. It is thought to play a role in the processing of proteins that are initially processed by furin or related endopeptidases present in the trans Golgi network, such as growth factors and receptors. CPD is implicated in the pathogenesis of lupus erythematosus (LE), it is regulated by TGF-beta in various cell types of murine and human origin and is significantly down-regulated in CD14 positive cells isolated from patients with LE. As down-regulation of CPD leads to down-modulation of TGF-beta, CPD may have a role in a positive feedback loop. In D. melanogaster, the CPD variant 1B short (DmCPD1Bs) is necessary and sufficient for viability of the fruit fly.


Pssm-ID: 349440  Cd Length: 294  Bit Score: 319.96  E-value: 6.40e-106
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371  47 YHRYAELREALVAVWLQCPAVSRIYTVGRSSEGRELLVIEVSDRPGEHEPGElkrdeewlcvtskstvdpsycmeevsll 126
Cdd:cd03868     1 YHNYDELTDLLHKLAETYPNIAKLHSIGKSVQGRELWVLEISDNVNRREPGK---------------------------- 52
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 127 fcgtiantpradmnnhtgvvvnalklkpgePEFKYVGNMHGNEAVGRELLIFLAQYLCNEYQKgNETIINLIHSTQytnl 206
Cdd:cd03868    53 ------------------------------PMFKYVANMHGDETVGRQLLIYLAQYLLENYGK-DERVTRLVNSTD---- 97
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 207 safmvketvklfiqqpdrraaknlraLYLMskrmsPSSgnNKVGFVIKLPGEL--KDWFVGRSNAQGIDLNRNFPDLDRi 284
Cdd:cd03868    98 --------------------------IHLM-----PSM--NPDGFENSKEGDCsgDPGYGGRENANNVDLNRNFPDQFE- 143
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 285 vyvnekeggpnnhllknmKKAVDQNPKLAPETKGVIHWIMDIPFVLSANLHGGDLVANYPYDETRSGSAH-EYSSCPDDA 363
Cdd:cd03868   144 ------------------DSDDRLLEGRQPETLAMMKWIVENPFVLSANLHGGSVVASYPFDDSPSHIECgVYSKSPDDA 205
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 364 IFQSLARSYSSLNPAMSdpNRPPCrkndDDSSFVDGTTNGGAWYSVPGGMQDFNYLSSNCFEITVELSCEKFPPEETLKG 443
Cdd:cd03868   206 VFRHLAHTYADNHPTMH--KGNNC----CEDSFKDGITNGAEWYDVPGGMQDFNYVHSNCFEITLELSCCKYPPASELPK 279
                         410
                  ....*....|....*
gi 1215457371 444 YWEDNKNSLINYIEQ 458
Cdd:cd03868   280 EWDNNKEALLSYMEQ 294
M14_CPX_like cd03869
Peptidase M14 carboxypeptidase subfamily N/E-like; Carboxypeptidase X subgroup; Peptidase ...
47-458 7.24e-98

Peptidase M14 carboxypeptidase subfamily N/E-like; Carboxypeptidase X subgroup; Peptidase M14-like domain of carboxypeptidase (CP)-like protein X (CPX), CPX forms a distinct subgroup of the N/E subfamily of the M14 family of metallocarboxypeptidases (MCPs). The M14 family are zinc-binding CPs which hydrolyze single, C-terminal amino acids from polypeptide chains, and have a recognition site for the free C-terminal carboxyl group, which is a key determinant of specificity. Proteins belonging to this subgroup include CP-like protein X1 (CPX1), CP-like protein X2 (CPX2), and aortic CP-like protein (ACLP) and its isoform adipocyte enhancer binding protein-1 (AEBP1). AEBP1 is a truncated form of ACLP, which may arise from alternative splicing of the gene. These proteins are inactive towards standard CP substrates because they lack one or more critical active site and substrate-binding residues that are necessary for activity. They may function as binding proteins rather than as active CPs or display catalytic activity toward other substrates. Proteins in this subgroup also contain an N-terminal discoidin domain. The CP domain is important for the function of AEBP1 as a transcriptional repressor. AEBP1 is involved in several biological processes including adipogenesis, macrophage cholesterol homeostasis, and inflammation. In macrophages, AEBP1 promotes the expression of IL-6, TNF-alpha, MCP-1, and iNOS whose expression is tightly regulated by NF-kappaB activity. ACLP, a secreted protein that associates with the extracellular matrix, is essential for abdominal wall development and contributes to dermal wound healing.


Pssm-ID: 349441  Cd Length: 322  Bit Score: 300.21  E-value: 7.24e-98
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371  47 YHRYAELREALVAVWLQCPAVSRIYTVGRSSEGRELLVIEVSDRPGEHEPGElkrdeewlcvtskstvdpsycmeevsll 126
Cdd:cd03869     1 HHNYKDMRQLMKVVNEMCPNITRIYNIGKSYQGLKLYAMEISDNPGEHEVGE---------------------------- 52
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 127 fcgtiantpradmnnhtgvvvnalklkpgePEFKYVGNMHGNEAVGRELLIFLAQYLCNEYQKGNETIINLIHSTQytnl 206
Cdd:cd03869    53 ------------------------------PEFRYVAGAHGNEVLGRELLLLLMQFLCQEYLAGNPRIRHLVEETR---- 98
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 207 safmvketvklfiqqpdrraaknlraLYLMskrmsPSSGNNKVGFVIKLPGELKDWFVGRSNAQGIDLNRNFPDLDRIVY 286
Cdd:cd03869    99 --------------------------IHLL-----PSVNPDGYEKAYEAGSELGGWSLGRWTSDGIDINHNFPDLNSLLW 147
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 287 VNEKEGG-----PNNHLlKNMKKAVDQNPKLAPETKGVIHWIMDIPFVLSANLHGGDLVANYPYDETRS-GSAHEYSSCP 360
Cdd:cd03869   148 EAEDRKWvprkvPNHHI-PIPEWYLSENATVAPETRAVIAWMEKIPFVLGGNLQGGELVVSYPYDMTRTpWKTQEYTPTP 226
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 361 DDAIFQSLARSYSSLNPAMSDPNRPPCrkNDDDSSFVDGTTNGGAWYSVPGGMQDFNYLSSNCFEITVELSCEKFPPEET 440
Cdd:cd03869   227 DDHVFRWLAYSYASTHRLMTDASRRPC--HTEDFQKEDGTVNGASWHTVAGSMNDFSYLHTNCFELSIYLGCDKFPHESE 304
                         410
                  ....*....|....*...
gi 1215457371 441 LKGYWEDNKNSLINYIEQ 458
Cdd:cd03869   305 LPEEWENNRESLLVFMEQ 322
M14_CPZ cd03867
Peptidase M14 carboxypeptidase subfamily N/E-like; Carboxypeptidase Z subgroup; Peptidase ...
47-457 4.06e-95

Peptidase M14 carboxypeptidase subfamily N/E-like; Carboxypeptidase Z subgroup; Peptidase M14-like domain of carboxypeptidase (CP) Z (CPZ), CPZ belongs to the N/E subfamily of the M14 family of metallocarboxypeptidases (MCPs). The M14 family are zinc-binding CPs which hydrolyze single, C-terminal amino acids from polypeptide chains, and have a recognition site for the free C-terminal carboxyl group, which is a key determinant of specificity. CPZ is a secreted Zn-dependent enzyme whose biological function is largely unknown. Unlike other members of the N/E subfamily, CPZ has a bipartite structure, which consists of an N-terminal cysteine-rich domain (CRD) whose sequence is similar to Wnt-binding proteins, and a C-terminal CP catalytic domain that removes C-terminal Arg residues from substrates. CPZ is enriched in the extracellular matrix and is widely distributed during early embryogenesis. That the CRD of CPZ can bind to Wnt4 suggests that CPZ plays a role in Wnt signaling.


Pssm-ID: 349439  Cd Length: 315  Bit Score: 292.95  E-value: 4.06e-95
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371  47 YHRYAELREALVAVWLQCPAVSRIYTVGRSSEGRELLVIEVSDRPGEHEPGElkrdeewlcvtskstvdpsycmeevsll 126
Cdd:cd03867     1 HHSYSQMVRVLKKTAARCAHIARTYSIGRSFEGKDLLVIEFSSNPGQHELLE---------------------------- 52
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 127 fcgtiantpradmnnhtgvvvnalklkpgePEFKYVGNMHGNEAVGRELLIFLAQYLCNEYQKGNETIINLIHSTQYTNL 206
Cdd:cd03867    53 ------------------------------PEVKYIGNMHGNEVVGREMLIYLAQYLCSEYLLGNPRIQTLINTTRIHLL 102
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 207 SAFmvketvklfiqQPDRRAAKNLRAlylmskrmspsSGNNKvgfviklpgelkdWFVGRSNAQGIDLNRNFPDLDRIVY 286
Cdd:cd03867   103 PSM-----------NPDGYEVAAEEG-----------AGYNG-------------WTSGRQNAQNLDLNRNFPDLTSEAY 147
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 287 -VNEKEGGPNNHLlknmkkAVDQN---PKLAPETKGVIHWIMDIPFVLSANLHGGDLVANYPYDETRSG-SAHEYSSCPD 361
Cdd:cd03867   148 rLARTRGARLDHI------PIPQSywwGKVAPETKAVMKWMRSIPFVLSASLHGGDLVVSYPYDFSKHPlEEKMFSPTPD 221
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 362 DAIFQSLARSYSSLNPAMSDPNRPPCRKNDDDSSfvdGTTNGGAWYSVPGGMQDFNYLSSNCFEITVELSCEKFPPEETL 441
Cdd:cd03867   222 EKMFKLLAKAYADAHPMMSDRSENRCGGNFLKRG---GIINGAEWYSFTGGMADFNYLHTNCFEVTVELGCEKFPPEEEL 298
                         410
                  ....*....|....*.
gi 1215457371 442 KGYWEDNKNSLINYIE 457
Cdd:cd03867   299 YTIWQENKEALLNFME 314
M14_CPD_II cd03863
Peptidase M14 carboxypeptidase subfamily N/E-like; Carboxypeptidase D, domain II subgroup; The ...
45-458 2.36e-86

Peptidase M14 carboxypeptidase subfamily N/E-like; Carboxypeptidase D, domain II subgroup; The second carboxypeptidase (CP)-like domain of Carboxypeptidase D (CPD; EC 3.4.17.22), domain II. CPD differs from all other metallocarboxypeptidases in that it contains multiple CP-like domains. CPD belongs to the N/E-like subfamily of the M14 family of metallocarboxypeptidases (MCPs).The M14 family are zinc-binding CPs which hydrolyze single, C-terminal amino acids from polypeptide chains, and have a recognition site for the free C-terminal carboxyl group, which is a key determinant of specificity. CPD is a single-chain protein containing a signal peptide, three tandem repeats of CP-like domains separated by short bridge regions, followed by a transmembrane domain, and a C-terminal cytosolic tail. The first two CP-like domains of CPD contain all of the essential active site and substrate-binding residues, while the third CP-like domain lacks critical residues necessary for enzymatic activity and is inactive towards standard CP substrates. Domain I is optimally active at pH 6.3-7.5 and prefers substrates with C-terminal Arg, whereas domain II is active at pH 5.0-6.5 and prefers substrates with C-terminal Lys. CPD functions in the processing of proteins that transit the secretory pathway, and is present in all vertebrates as well as Drosophila. It is broadly distributed in all tissue types. Within cells, CPD is present in the trans-Golgi network and immature secretory vesicles, but is excluded from mature vesicles. It is thought to play a role in the processing of proteins that are initially processed by furin or related endopeptidases present in the trans-Golgi network, such as growth factors and receptors. CPD is implicated in the pathogenesis of lupus erythematosus (LE), it is regulated by TGF-beta in various cell types of murine and human origin and is significantly down-regulated in CD14 positive cells isolated from patients with LE. As down -regulation of CPD leads to down-modulation of TGF-beta, CPD may have a role in a positive feedback loop.


Pssm-ID: 349435 [Multi-domain]  Cd Length: 296  Bit Score: 269.51  E-value: 2.36e-86
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371  45 FEYHRYAELREALVAVWLQCPAVSRIYTVGRSSEGRELLVIEVSDRPGEHEPGElkrdeewlcvtskstvdpsycmeevs 124
Cdd:cd03863     6 FRHHHFSDMEIFLRRYANEYPSITRLYSVGKSVELRELYVMEISDNPGVHEPGE-------------------------- 59
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 125 llfcgtiantpradmnnhtgvvvnalklkpgePEFKYVGNMHGNEAVGRELLIFLAQYLCNEYQKGNEtIINLIHSTQyt 204
Cdd:cd03863    60 --------------------------------PEFKYIGNMHGNEVVGRELLLNLIEYLCKNFGTDPE-VTDLVQNTR-- 104
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 205 nlsafmvketvklfiqqpdrraaknlraLYLMSKrMSPSsgnnkvGFVIKLPGElKDWFVGRSNAQGIDLNRNFPDldRI 284
Cdd:cd03863   105 ----------------------------IHIMPS-MNPD------GYEKSQEGD-RGGTVGRNNSNNYDLNRNFPD--QF 146
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 285 VYVNEKeggpnnhllknmkkavdqnpkLAPETKGVIHWIMDIPFVLSANLHGGDLVANYPYDETRSGSAhEYSSCPDDAI 364
Cdd:cd03863   147 FQITDP---------------------PQPETLAVMSWLKTYPFVLSANLHGGSLVVNYPFDDDEQGLA-TYSKSPDDAV 204
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 365 FQSLARSYSSLNPAMSDPNrpPCRKNDDDSSFVDGTTNGGAWYSVPGGMQDFNYLSSNCFEITVELSCEKFPPEETLKGY 444
Cdd:cd03863   205 FQQLALSYSKENSKMYQGS--PCKELYPNEYFPHGITNGAQWYNVPGGMQDWNYLNTNCFEVTIELGCVKYPKAEELPKY 282
                         410
                  ....*....|....
gi 1215457371 445 WEDNKNSLINYIEQ 458
Cdd:cd03863   283 WEQNRRSLLQFIKQ 296
M14_CP_plant cd18172
Zinc carboxypeptidase, including SOL1, a carboxypeptidase D in plant; This family includes ...
47-457 6.22e-78

Zinc carboxypeptidase, including SOL1, a carboxypeptidase D in plant; This family includes only plant members of the carboxypeptidase (CP) N/E-like subfamily of the M14 family of metallocarboxypeptidases (MCPs). It includes Arabidopsis thaliana SOL1 carboxypeptidase D which is known to possess enzymatic activity to remove the C-terminal arginine residue of CLE19 proprotein in vitro, and SOL1-dependent cleavage of the C-terminal arginine residue is necessary for CLE19 activity in vivo. The M14 family are zinc-binding CPs which hydrolyze single, C-terminal amino acids from polypeptide chains, and have a recognition site for the free C-terminal carboxyl group, which is a key determinant of specificity. The N/E subfamily includes eight members, of which five (CPN, CPE, CPM, CPD, CPZ) are considered enzymatically active, while the other three are non-active (CPX1, PCX2, ACLP/AEBP1) and lack the critical active site and substrate-binding residues considered necessary for CP activity. These non-active members may function as binding proteins or display catalytic activity towards other substrates. Unlike the A/B CP subfamily, enzymes belonging to the N/E subfamily are not produced as inactive precursors that require proteolysis to produce the active form; rather, they rely on their substrate specificity and subcellular compartmentalization to prevent inappropriate cleavages that would otherwise damage the cell. In addition, all members of the N/E subfamily contain an extra C-terminal domain that is not present in the A/B subfamily. This domain has structural homology to transthyretin and other proteins and has been proposed to function as a folding domain. The active N/E enzymes fulfill a variety of cellular functions, including prohormone processing, regulation of peptide hormone activity, alteration of protein-protein or protein-cell interactions and transcriptional regulation.


Pssm-ID: 349482 [Multi-domain]  Cd Length: 276  Bit Score: 246.94  E-value: 6.22e-78
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371  47 YHRYAELREALVAVWLQCPAVSRIYTVGRSSEGRELLVIEVSDRPGEHEPgelkrdeewlcvtskstvdpsycmeevsll 126
Cdd:cd18172     1 YHSNAELEDALKAFTRRCGAISRLIVIGSSVNGFPLWALEISDGPGEDET------------------------------ 50
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 127 fcgtiantpradmnnhtgvvvnalklkpgEPEFKYVGNMHGNEAVGRELLIFLAQYLCNEYQKGNEtiinlihstqytnL 206
Cdd:cd18172    51 -----------------------------EPAFKFVGNMHGDEPVGRELLLRLADWLCANYKAKDP-------------L 88
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 207 SAFMVKETvklfiqqpdrraaknlrALYLMSKrMSPSsgnnkvGFVIKLpgelkdwfvgRSNAQGIDLNRNFPDldrivy 286
Cdd:cd18172    89 AAKIVENA-----------------HLHLVPT-MNPD------GFARRR----------RNNANNVDLNRDFPD------ 128
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 287 vnekEGGPNNhllknmkkAVDQNPKLAPETKGVIHWIMDIPFVLSANLHGGDLVANYPYDETRSGSAHeYSSCPDDAIFQ 366
Cdd:cd18172   129 ----QFFPKN--------LRNDLAARQPETLAVMNWSRSVRFTASANLHEGALVANYPWDGNADGRTK-YSASPDDATFR 195
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 367 SLARSYSSLNPAMSDPnrppcrkndddSSFVDGTTNGGAWYSVPGGMQDFNYLSSNCFEITVELSCEKFPPEETLKGYWE 446
Cdd:cd18172   196 RLASVYAQAHPNMAKS-----------KEFPGGITNGAQWYPLYGGMQDWNYLHTGCMDLTLEVNDNKWPPEDRLVQIWA 264
                         410
                  ....*....|.
gi 1215457371 447 DNKNSLINYIE 457
Cdd:cd18172   265 EHRKAMLALAA 275
M14_CPM cd03866
Peptidase M14 carboxypeptidase subfamily N/E-like; Carboxypeptidase M subgroup; Peptidase M14 ...
47-458 4.62e-77

Peptidase M14 carboxypeptidase subfamily N/E-like; Carboxypeptidase M subgroup; Peptidase M14 Carboxypeptidase (CP) M (CPM) belongs to the N/E subfamily of the M14 family of metallocarboxypeptidases (MCPs).The M14 family are zinc-binding CPs which hydrolyze single, C-terminal amino acids from polypeptide chains, and have a recognition site for the free C-terminal carboxyl group, which is a key determinant of specificity. CPM is an extracellular glycoprotein, bound to cell membranes via a glycosyl-phosphatidylinositol on the C-terminus of the protein. It specifically removes C-terminal basic residues such as lysine and arginine from peptides and proteins. The highest levels of CPM have been found in human lung and placenta, but significant amounts are present in kidney, blood vessels, intestine, brain, and peripheral nerves. CPM has also been found in soluble form in various body fluids, including amniotic fluid, seminal plasma and urine. Due to its wide distribution in a variety of tissues, it is believed that it plays an important role in the control of peptide hormones and growth factor activity on the cell surface and in the membrane-localized degradation of extracellular proteins, for example it hydrolyses the C-terminal arginine of epidermal growth factor (EGF) resulting in des-Arg-EGF which binds to the EGF receptor (EGFR) with an equal or greater affinity than native EGF. CPM is a required processing enzyme that generates specific agonists for the B1 receptor.


Pssm-ID: 349438  Cd Length: 289  Bit Score: 245.09  E-value: 4.62e-77
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371  47 YHRYAELREALVAVWLQCPAVSRIYTVGRSSEGRELLVIEVSDRPGEHepgelkrdeewlcvtskstvdpsycmeevsll 126
Cdd:cd03866     1 YHNQEQMETYLKDVNKNYPSITHLHSIGKSVEGRDLWVLVLGRFPTKH-------------------------------- 48
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 127 fcgtiantpradmnnhtgvvvnalklKPGEPEFKYVGNMHGNEAVGRELLIFLAQYLCNEYQKgNETIINLIHSTQytnl 206
Cdd:cd03866    49 --------------------------RIGIPEFKYVANMHGDEVVGRELLLHLIEFLVTSYGS-DPVITRLINSTR---- 97
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 207 safmvketvklfiqqpdrraaknlraLYLMSKrMSPSsgnnkvGFVI-KLPGELkdWFVGRSNAQGIDLNRNFPDldriv 285
Cdd:cd03866    98 --------------------------IHIMPS-MNPD------GFEAtKKPDCY--YTKGRYNKNGYDLNRNFPD----- 137
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 286 yvnekeggpnnhllknmkkAVDQNP-KLAPETKGVIHWIMDIPFVLSANLHGGDLVANYPYDETRSGSA--HEYSSCPDD 362
Cdd:cd03866   138 -------------------AFEENNvQRQPETRAVMDWIKNETFVLSANLHGGALVASYPFDNGNSGTGqlGYYSVSPDD 198
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 363 AIFQSLARSYSSLNPAMSDPNRppCrknDDDSSFVDGTTNGGAWYSVPGGMQDFNYLSSNCFEITVELSCEKFPPEETLK 442
Cdd:cd03866   199 DVFIYLAKTYSYNHTNMYKGIE--C---SNSQSFPGGITNGYQWYPLQGGMQDYNYVWGQCFEITLELSCCKYPPEETLP 273
                         410
                  ....*....|....*.
gi 1215457371 443 GYWEDNKNSLINYIEQ 458
Cdd:cd03866   274 QFWNDNRVALIEYIKQ 289
M14_CP_bacteria cd18173
bacterial peptidase M14 carboxypeptidase, uncharacterized; This family contains only bacterial ...
47-458 1.49e-70

bacterial peptidase M14 carboxypeptidase, uncharacterized; This family contains only bacterial carboxypeptidase (CP) members of the M14 family of metallocarboxypeptidases (MCPs), mostly of which have yet to be characterized. The M14 family are zinc-binding CPs which hydrolyze single, C-terminal amino acids from polypeptide chains, and have a recognition site for the free C-terminal carboxyl group, which is a key determinant of specificity. The N/E subfamily includes eight members, of which five (CPN, CPE, CPM, CPD, CPZ) are considered enzymatically active, while the other three are non-active (CPX1, PCX2, ACLP/AEBP1) and lack the critical active site and substrate-binding residues considered necessary for CP activity. These non-active members may function as binding proteins or display catalytic activity towards other substrates. Unlike the A/B CP subfamily, enzymes belonging to the N/E subfamily are not produced as inactive precursors that require proteolysis to produce the active form; rather, they rely on their substrate specificity and subcellular compartmentalization to prevent inappropriate cleavages that would otherwise damage the cell. In addition, all members of the N/E subfamily contain an extra C-terminal domain that is not present in the A/B subfamily. This domain has structural homology to transthyretin and other proteins and has been proposed to function as a folding domain. The active N/E enzymes fulfill a variety of cellular functions, including prohormone processing, regulation of peptide hormone activity, alteration of protein-protein or protein-cell interactions and transcriptional regulation.


Pssm-ID: 349483 [Multi-domain]  Cd Length: 281  Bit Score: 227.85  E-value: 1.49e-70
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371  47 YHRYAELREALVAVWLQCPAVSRIYTVGRSSEGRELLVIEVSDRPGEHEPgelkrdeewlcvtskstvdpsycmeevsll 126
Cdd:cd18173     4 YPTYEEYEAMMQSFAANYPNICRLVSIGTSVQGRKLLALKISDNVNTEEA------------------------------ 53
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 127 fcgtiantpradmnnhtgvvvnalklkpgEPEFKYVGNMHGNEAVGRELLIFLAQYLCNEYQKgNETIINLIHSTQ-YTN 205
Cdd:cd18173    54 -----------------------------EPEFKYTSTMHGDETTGYELMLRLIDYLLTNYGT-DPRITNLVDNTEiWIN 103
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 206 LSAfmvketvklfiqQPDRRAAknlralylmskrmspsSGNNKVGFVIklpgelkdwfvgRSNAQGIDLNRNFPDldriv 285
Cdd:cd18173   104 PLA------------NPDGTYA----------------GGNNTVSGAT------------RYNANGVDLNRNFPD----- 138
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 286 yvneKEGGPNNhllknmkkavDQNPkLAPETKGVIHWIMDIPFVLSANLHGGDLVANYPYDetrsgsaHEYSSCPDDAIF 365
Cdd:cd18173   139 ----PVDGDHP----------DGNG-WQPETQAMMNFADEHNFVLSANFHGGAEVVNYPWD-------TWYSRHPDDDWF 196
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 366 QSLARSYSSLNPAMSDPNRppcrknddDSSFVDGTTNGGAWYSVPGGMQDFNYLSSNCFEITVELSCEKFPPEETLKGYW 445
Cdd:cd18173   197 QDISREYADTNQANSPPMY--------MSEFNNGITNGYDWYEVYGGRQDYMYYWHGCREVTIELSNTKWPPASQLPTYW 268
                         410
                  ....*....|...
gi 1215457371 446 EDNKNSLINYIEQ 458
Cdd:cd18173   269 NYNRESLLNYIEQ 281
Peptidase_M14 pfam00246
Zinc carboxypeptidase;
53-451 5.95e-64

Zinc carboxypeptidase;


Pssm-ID: 459730 [Multi-domain]  Cd Length: 287  Bit Score: 211.00  E-value: 5.95e-64
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371  53 LREALVAVWLQCPAVSRIYTVGRSSEGRELLVIEVSDRPGEHepgelkrdeewlcvtskstvdpsycmeevsllfcgtia 132
Cdd:pfam00246   1 IEAWLDALAARYPDLVRLVSIGKSVEGRPLKVLKISSGPGEH-------------------------------------- 42
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 133 ntpradmnnhtgvvvnalklKPGEPEFKYVGNMHGNEAVGRELLIFLAQYLCNEYQKgNETIINLIHSTqytnlsafmvk 212
Cdd:pfam00246  43 --------------------NPGKPAVFIDGGIHAREWIGPATALYLIHQLLTNYGR-DPEITELLDDT----------- 90
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 213 eTVKLFIQ-QPDrraaknlralylmskrmspssgnnkvGFVIKLPGElKDWFVGRSNAQ-----GIDLNRNFPDL----- 281
Cdd:pfam00246  91 -DIYILPVvNPD--------------------------GYEYTHTTD-RLWRKNRSNANgssciGVDLNRNFPDHwnevg 142
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 282 DRIVYVNEKEGGPNNHLlknmkkavdqnpklAPETKGVIHWIMD-IPFVLSANLHGGDLVANYPYDETRSgsaheySSCP 360
Cdd:pfam00246 143 ASSNPCSETYRGPAPFS--------------EPETRAVADFIRSkKPFVLYISLHSYSQVLLYPYGYTRD------EPPP 202
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 361 DDAIFQSLARSYSSLNPAMSDpnrppcrknddDSSFVDGTTNGGAWYSVPGGMQDFNYLSSNC-FEITVELSCEK----F 435
Cdd:pfam00246 203 DDEELKSLARAAAKALQKMVR-----------GTSYTYGITNGATIYPASGGSDDWAYGRLGIkYSYTIELRDTGrygfL 271
                         410
                  ....*....|....*.
gi 1215457371 436 PPEETLKGYWEDNKNS 451
Cdd:pfam00246 272 LPASQIIPTAEETWEA 287
M14_CPD_III cd06245
Peptidase M14 carboxypeptidase subfamily N/E-like; Carboxypeptidase D, domain III subgroup; ...
47-458 1.04e-43

Peptidase M14 carboxypeptidase subfamily N/E-like; Carboxypeptidase D, domain III subgroup; The third carboxypeptidase (CP)-like domain of Carboxypeptidase D (CPD; EC 3.4.17.22), domain III. CPD differs from all other metallocarboxypeptidases in that it contains multiple CP-like domains. CPD belongs to the N/E-like subfamily of the M14 family of metallocarboxypeptidases (MCPs).The M14 family are zinc-binding CPs which hydrolyze single, C-terminal amino acids from polypeptide chains, and have a recognition site for the free C-terminal carboxyl group, which is a key determinant of specificity. CPD is a single-chain protein containing a signal peptide, three tandem repeats of CP-like domains separated by short bridge regions, followed by a transmembrane domain, and a C-terminal cytosolic tail. The first two CP-like domains of CPD contain all of the essential active site and substrate-binding residues, the third CP-like domain lacks critical residues necessary for enzymatic activity and is inactive towards standard CP substrates. Domain I is optimally active at pH 6.3-7.5 and prefers substrates with C-terminal Arg, whereas domain II is active at pH 5.0-6.5 and prefers substrates with C-terminal Lys. CPD functions in the processing of proteins that transit the secretory pathway, and is present in all vertebrates as well as Drosophila. It is broadly distributed in all tissue types. Within cells, CPD is present in the trans-Golgi network and immature secretory vesicles, but is excluded from mature vesicles. It is thought to play a role in the processing of proteins that are initially processed by furin or related endopeptidases present in the trans-Golgi network, such as growth factors and receptors. CPD is implicated in the pathogenesis of lupus erythematosus (LE), it is regulated by TGF-beta in various cell types of murine and human origin and is significantly down-regulated in CD14 positive cells isolated from patients with LE. As down -regulation of CPD leads to down-modulation of TGF-beta, CPD may have a role in a positive feedback loop.


Pssm-ID: 349464 [Multi-domain]  Cd Length: 283  Bit Score: 156.84  E-value: 1.04e-43
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371  47 YHRYAELREALVAVWLQCPAVSRIYTVGRSSEGRELLVIEVSDRPGEHEPGElkrdeewlcvtskstvdpsycmeevsll 126
Cdd:cd06245     1 YHSYKQLSKFLRGLNSNYPTITNLTSLGQSVEKRDIWVLEIGNKPNESEPSE---------------------------- 52
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 127 fcgtiantpradmnnhtgvvvnalklkpgePEFKYVGNMHGNEAVGRELLIFLAQYLCNEYQKgNETIINLIHSTQ-YTN 205
Cdd:cd06245    53 ------------------------------PKILFVGGIHGNAPVGTELLLLLAHFLCHNYKK-DSAITKLLNRTRiHIV 101
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 206 LSAfmvketvklfiqQPDRRAAKNlralylmSKRMSPSSGNNkvgfviklpgelkdwfvgrsNAQGIDLNRNFPdldriv 285
Cdd:cd06245   102 PSL------------NPDGAEKAE-------EKKCTSKIGEK--------------------NANGVDLDTDFE------ 136
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 286 yvnEKEGGPNNHLlknmkkavdqnpklAPETKGVIHWIMDIPFVLSANLHGGDLVANYPYDETRSGSAHEysscpddAIF 365
Cdd:cd06245   137 ---SNANNRSGAA--------------QPETKAIMDWLKEKDFTLSVALDGGSLVVTYPYDKPVQTVENK-------ETL 192
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 366 QSLARSYSSLNPAM--SDPNRPpcrkNDDDSSFVDGTTNGGAWYSVPGGMQDFNYLSSNCFEITVELSCEKFPPEETLKG 443
Cdd:cd06245   193 KHLAKVYANNHPTMhaGDPGCC----SNSDENFTNGVIRASEWHSHKGSMLDFSYKFGSCPEITVYTSCCYFPPAEELLT 268
                         410
                  ....*....|....*
gi 1215457371 444 YWEDNKNSLINYIEQ 458
Cdd:cd06245   269 LWAEHKKSLLSMIVE 283
Zn_pept smart00631
Zn_pept domain;
47-441 1.31e-43

Zn_pept domain;


Pssm-ID: 214748 [Multi-domain]  Cd Length: 277  Bit Score: 156.34  E-value: 1.31e-43
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371   47 YHRYAELREALVAVWLQCPAVSRIYTVGRSSEGRELLVIEVSDRPGehepgelkrdeewlcvtskstvdpsycmeevsll 126
Cdd:smart00631   1 YHSYEEIEAWLKELAARYPDLVRLVSIGKSVEGRPIWVLKISNGGS---------------------------------- 46
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371  127 fcgtiantpradmnnhtgvvvnalklkPGEPEFKYVGNMHGNEAVGRELLIFLAQYLCNEYQKgNETIINLIHSTQytnl 206
Cdd:smart00631  47 ---------------------------HDKPAIFIDAGIHAREWIGPATALYLINQLLENYGR-DPRVTNLLDKTD---- 94
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371  207 safmvketvklfiqqpdrraaknlraLYLMSkRMSPSsgnnkvGFVIKLPGElKDWFVGRS---NAQGIDLNRNFPDLdr 283
Cdd:smart00631  95 --------------------------IYIVP-VLNPD------GYEYTHTGD-RLWRKNRSpnsNCRGVDLNRNFPFH-- 138
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371  284 ivyvNEKEGGPNNHLLKNmkkavdQNPKLAPETKGVIHWIMD-IPFVLSANLHGGDLVANYPYDETRSGSAHEYSScpDD 362
Cdd:smart00631 139 ----WGETGNPCSETYAG------PSPFSEPETKAVRDFIRSnRRFKLYIDLHSYSQLILYPYGYTKNDLPPNVDD--LD 206
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371  363 AIFQSLARSYSSLNPamsdpnrppcrkndddSSFVDGTTNGGAWYsVPGGMQDFNYLSSN-CFEITVELSCE-----KFP 436
Cdd:smart00631 207 AVAKALAKALASVHG----------------TRYTYGISNGAIYP-ASGGSDDWAYGVLGiPFSFTLELRDDgrygfLLP 269

                   ....*
gi 1215457371  437 PEETL 441
Cdd:smart00631 270 PSQII 274
Peptidase_M14NE-CP-C_like cd11308
Peptidase associated domain: C-terminal domain of M14 N/E carboxypeptidase; putative folding, ...
462-536 2.77e-40

Peptidase associated domain: C-terminal domain of M14 N/E carboxypeptidase; putative folding, regulation, or interaction domain; This domain is found C-terminal to the M14 carboxypeptidase (CP) N/E subfamily containing zinc-binding enzymes that hydrolyze single C-terminal amino acids from polypeptide chains, and have a recognition site for the free C-terminal carboxyl group, which is a key determinant of specificity. The N/E subfamily includes enzymatically active members (carboxypeptidase N, E, M, D, and Z), as well as non-active members (carboxypeptidase-like protein 1, -2, aortic CP-like protein, and adipocyte enhancer binding protein-1) which lack the critical active site and substrate-binding residues considered necessary for activity. The active N/E enzymes fulfill a variety of cellular functions, including prohormone processing, regulation of peptide hormone activity, alteration of protein-protein or protein-cell interactions and transcriptional regulation. For M14 CPs, it has been suggested that this domain may assist in folding of the CP domain, regulate enzyme activity, or be involved in interactions with other proteins or with membranes; for carboxypeptidase M, it may interact with the bradykinin 1 receptor at the cell surface. This domain may also be found in other peptidase families.


Pssm-ID: 200604 [Multi-domain]  Cd Length: 76  Bit Score: 140.74  E-value: 2.77e-40
                          10        20        30        40        50        60        70
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1215457371 462 GVKGFVKDLQGNPIANATISVEGISHDITSAKDGDYWRLLVPGNYKLTASAPGYLAITKKVAVPFSP-AVVVDFEL 536
Cdd:cd11308     1 GIKGFVTDATGNPIANATISVEGINHDVTTAKDGDYWRLLLPGTYNVTASAPGYQPVTKTVTVPNNFsATVVNFTL 76
Peptidase_M14_like cd00596
M14 family of metallocarboxypeptidases and related proteins; The M14 family of ...
161-452 9.31e-21

M14 family of metallocarboxypeptidases and related proteins; The M14 family of metallocarboxypeptidases (MCPs), also known as funnelins, are zinc-binding carboxypeptidases (CPs) which hydrolyze single, C-terminal amino acids from polypeptide chains, and have a recognition site for the free C-terminal carboxyl group, which is a key determinant of specificity. Two major subfamilies of the M14 family, defined based on sequence and structural homology, are the A/B and N/E subfamilies. Enzymes belonging to the A/B subfamily are normally synthesized as inactive precursors containing preceding signal peptide, followed by an N-terminal pro-region linked to the enzyme; these proenzymes are called procarboxypeptidases. The A/B enzymes can be further divided based on their substrate specificity; Carboxypeptidase A-like (CPA-like) enzymes favor hydrophobic residues while carboxypeptidase B-like (CPB-like) enzymes only cleave the basic residues lysine or arginine. The A forms have slightly different specificities, with Carboxypeptidase A1 (CPA1) preferring aliphatic and small aromatic residues, and CPA2 preferring the bulky aromatic side chains. Enzymes belonging to the N/E subfamily enzymes are not produced as inactive precursors and instead rely on their substrate specificity and subcellular compartmentalization to prevent inappropriate cleavage. They contain an extra C-terminal transthyretin-like domain, thought to be involved in folding or formation of oligomers. MCPs can also be classified based on their involvement in specific physiological processes; the pancreatic MCPs participate only in alimentary digestion and include carboxypeptidase A and B (A/B subfamily), while others, namely regulatory MCPs or the N/E subfamily, are involved in more selective reactions, mainly in non-digestive tissues and fluids, acting on blood coagulation/fibrinolysis, inflammation and local anaphylaxis, pro-hormone and neuropeptide processing, cellular response and others. Another MCP subfamily, is that of succinylglutamate desuccinylase /aspartoacylase, which hydrolyzes N-acetyl-L-aspartate (NAA), and deficiency in which is the established cause of Canavan disease. Another subfamily (referred to as subfamily C) includes an exceptional type of activity in the MCP family, that of dipeptidyl-peptidase activity of gamma-glutamyl-(L)-meso-diaminopimelate peptidase I which is involved in bacterial cell wall metabolism.


Pssm-ID: 349427 [Multi-domain]  Cd Length: 216  Bit Score: 90.98  E-value: 9.31e-21
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 161 YVGNMHGNEAVGRELLIFLAQYLCNEYqkGNETIINLIhstqytnlsafmvkETVKLFI---QQPDrraaknlralylms 237
Cdd:cd00596     3 ITGGIHGNEVIGVELALALIEYLLENY--GNDPLKRLL--------------DNVELWIvplVNPD-------------- 52
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 238 krmspssGNNKVGFviklpgelkdwFVGRSNAQGIDLNRNFPdldrivYVNEKEGGPNNHLLKNMkkavdqNPKLA--PE 315
Cdd:cd00596    53 -------GFARVID-----------SGGRKNANGVDLNRNFP------YNWGKDGTSGPSSPTYR------GPAPFsePE 102
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 316 TKGVIHWIMDIPFVLSANLHGGDLVANYPYdetrsgsAHEYSSCPDDAIFQSLARSYSSLNPAmsdpnrppcrkndddss 395
Cdd:cd00596   103 TQALRDLAKSHRFDLAVSYHSSSEAILYPY-------GYTNEPPPDFSEFQELAAGLARALGA----------------- 158
                         250       260       270       280       290
                  ....*....|....*....|....*....|....*....|....*....|....*...
gi 1215457371 396 FVDGTTNGGAWYSVPGGMQDFNYLSSNCFEITVEL-SCEKFPPEETLKGYWEDNKNSL 452
Cdd:cd00596   159 GEYGYGYSYTWYSTTGTADDWLYGELGILAFTVELgTADYPLPGTLLDRRLERNLAAL 216
CarboxypepD_reg pfam13620
Carboxypeptidase regulatory-like domain;
462-536 5.58e-16

Carboxypeptidase regulatory-like domain;


Pssm-ID: 433354 [Multi-domain]  Cd Length: 81  Bit Score: 73.08  E-value: 5.58e-16
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 462 GVKGFVKDLQGNPIANATISVE----GISHDITSAKDGDYW-RLLVPGNYKLTASAPGYLAITKK-VAVPFSPAVVVDFE 535
Cdd:pfam13620   1 TISGTVTDPSGAPVPGATVTVTntdtGTVRTTTTDADGRYRfPGLPPGTYTVTVSAPGFKTATRTgVTVTAGQTTTLDVT 80

                  .
gi 1215457371 536 L 536
Cdd:pfam13620  81 L 81
M14_CPT cd03859
Peptidase M14 Carboxypeptidase T subfamily; Peptidase M14-like domain of carboxypeptidase (CP) ...
47-448 3.18e-14

Peptidase M14 Carboxypeptidase T subfamily; Peptidase M14-like domain of carboxypeptidase (CP) T (CPT), CPT belongs to the M14 family of metallocarboxypeptidases (MCPs). The M14 family are zinc-binding CPs which hydrolyze single, C-terminal amino acids from polypeptide chains, and have a recognition site for the free C-terminal carboxyl group, which is a key determinant of specificity. CPT has moderate similarity to CPA and CPB, and exhibits dual-substrate specificity by cleaving C-terminal hydrophobic amino acid residues like CPA and C-terminal positively charged residues like CPB. CPA and CPB are M14 family peptidases but do not belong to this CPT group. The substrate specificity difference between CPT and CPA and CPB is ascribed to a few amino acid substitutions at the substrate-binding pocket while the spatial organization of the binding site remains the same as in all Zn-CPs. CPT has increased thermal stability in presence of Ca2+ ions, and two disulfide bridges which give an additional stabilization factor.


Pssm-ID: 349432 [Multi-domain]  Cd Length: 292  Bit Score: 73.44  E-value: 3.18e-14
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371  47 YHRYAELREALVAVWLQCPAVSRIYTVGRSSEGRELLVIEVSDRPGEhepgelkrdeewlcvtskstvdpsycmeevsll 126
Cdd:cd03859     4 YHTYAELVAELDQLAAEYPEITKLISIGKSVEGRPIWAVKISDNPDE--------------------------------- 50
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 127 fcgtiantpradmnnhtgvvvnalklKPGEPEFKYVGNMHGNEAVGRELLIFLAQYLCNEYQKgNETIINLIHSTqytnl 206
Cdd:cd03859    51 --------------------------DEDEPEVLFMGLHHAREWISLEVALYFADYLLENYGT-DPRITNLVDNR----- 98
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 207 safmvkETVKLFIQQPD--------------RraaKNLRalylmskrmsPSSGNNkvgfviklpgelkdwfvgrSNAQGI 272
Cdd:cd03859    99 ------EIWIIPVVNPDgyeynretgggrlwR---KNRR----------PNNGNN-------------------PGSDGV 140
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 273 DLNRNFPdldrivYV--NEKEGGPNNHllknmkkaVDQN-----PKLAPETKGVIHWIMDIPFVLSANLHG-GDLVaNYP 344
Cdd:cd03859   141 DLNRNYG------YHwgGDNGGSSPDP--------SSETyrgpaPFSEPETQAIRDLVESHDFKVAISYHSyGELV-LYP 205
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 345 YDETRSGSAheysscPDDAIFQSLARSYSSLNPAMSDPNrppcrkndddSSFVDGTTNGGAwysvpggmQDFNYLSSNCF 424
Cdd:cd03859   206 WGYTSDAPT------PDEDVFEELAEEMASYNGGGYTPQ----------QSSDLYPTNGDT--------DDWMYGEKGII 261
                         410       420
                  ....*....|....*....|....*..
gi 1215457371 425 EITVEL---SCEKFPPEETLKGYWEDN 448
Cdd:cd03859   262 AFTPELgpeFYPFYPPPSQIDPLAEEN 288
MpaA COG2866
Murein tripeptide amidase MpaA [Cell wall/membrane/envelope biogenesis];
46-383 4.72e-08

Murein tripeptide amidase MpaA [Cell wall/membrane/envelope biogenesis];


Pssm-ID: 442113 [Multi-domain]  Cd Length: 337  Bit Score: 55.08  E-value: 4.72e-08
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371  46 EYHRYAELREALVAVWLQCPAVsRIYTVGRSSEGRELLVIEVSDRpgehepgelkrdeewlcvtskstvdpsycmeevsl 125
Cdd:COG2866    18 RYYTYEELLALLAKLAAASPLV-ELESIGKSVEGRPIYLLKIGDP----------------------------------- 61
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 126 lfcgtiantpradmnnhtgvvvnalklKPGEPEFKYVGNMHGNEAVGRELLIFLAQYLCneyqkgnetiinlihsTQYTN 205
Cdd:COG2866    62 ---------------------------AEGKPKVLLNAQQHGNEWTGTEALLGLLEDLL----------------DNYDP 98
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 206 LSAFMVKETVKLFIqqPdrraaknlralylmskRMSPSsgnnkvgfviklpGELKDWfvgRSNAQGIDLNRNFPDLDRiv 285
Cdd:COG2866    99 LIRALLDNVTLYIV--P----------------MLNPD-------------GAERNT---RTNANGVDLNRDWPAPWL-- 142
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371 286 yvnekeggpnnhllknmkkavdqnpkLAPETKGVIHWIMDIPFVLSANLHGGDLVANYPYDETRSGSAHEYSSCPD--DA 363
Cdd:COG2866   143 --------------------------SEPETRALRDLLDEHDPDFVLDLHGQGELFYWFVGTTEPTGSFLAPSYDEerEA 196
                         330       340
                  ....*....|....*....|
gi 1215457371 364 IFQSLARSYSSLNPAMSDPN 383
Cdd:COG2866   197 FAEELNFEGIILAGSAFLGA 216
M14-like cd06905
Peptidase M14-like domain; uncharacterized subfamily; A functionally uncharacterized subgroup ...
47-187 2.89e-06

Peptidase M14-like domain; uncharacterized subfamily; A functionally uncharacterized subgroup of the M14 family of metallocarboxypeptidases (MCPs). The M14 family are zinc-binding carboxypeptidases (CPs) which hydrolyze single, C-terminal amino acids from polypeptide chains, and have a recognition site for the free C-terminal carboxyl group, which is a key determinant of specificity. Two major subfamilies of the M14 family, defined based on sequence and structural homology, are the A/B and N/E subfamilies. Enzymes belonging to the A/B subfamily are normally synthesized as inactive precursors containing preceding signal peptide, followed by an N-terminal pro-region linked to the enzyme; these proenzymes are called procarboxypeptidases. The A/B enzymes can be further divided based on their substrate specificity; Carboxypeptidase A-like (CPA-like) enzymes favor hydrophobic residues while carboxypeptidase B-like (CPB-like) enzymes only cleave the basic residues lysine or arginine. The A forms have slightly different specificities, with Carboxypeptidase A1 (CPA1) preferring aliphatic and small aromatic residues, and CPA2 preferring the bulky aromatic side chains. Enzymes belonging to the N/E subfamily enzymes are not produced as inactive precursors and instead rely on their substrate specificity and subcellular compartmentalization to prevent inappropriate cleavages. They contain an extra C-terminal transthyretin-like domain, thought to be involved in folding or formation of oligomers. MCPs can also be classified based on their involvement in specific physiological processes; the pancreatic MCPs participate only in alimentary digestion and include carboxypeptidase A and B (A/B subfamily), while others, namely regulatory MCPs or the N/E subfamily, are involved in more selective reactions, mainly in non-digestive tissues and fluids, acting on blood coagulation/fibrinolysis, inflammation and local anaphylaxis, pro-hormone and neuropeptide processing, cellular response and others. Another MCP subfamily, is that of succinylglutamate desuccinylase /aspartoacylase, which hydrolyzes N-acetyl-L-aspartate (NAA), and deficiency in which is the established cause of Canavan disease. Another subfamily (referred to as subfamily C) includes an exceptional type of activity in the MCP family, that of dipeptidyl-peptidase activity of gamma-glutamyl-(L)-meso-diaminopimelate peptidase I which is involved in bacterial cell wall metabolism.


Pssm-ID: 349476 [Multi-domain]  Cd Length: 359  Bit Score: 49.54  E-value: 2.89e-06
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1215457371  47 YHRYAELREALVAVWLQCPAVSRIYTVGRSSEGRELLVIEVSdrpgehepgelkrdeewlcvtskstvdpsycmeevsll 126
Cdd:cd06905     6 YYTYAELTARLKALAEAYPNLVRLESIGKSYEGRDIWLLTIT-------------------------------------- 47
                          90       100       110       120       130       140
                  ....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1215457371 127 fcgtiantpradmNNHTGvvvnALKLKPGepeFKYVGNMHGNEAVGRELLIFLAQYLCNEY 187
Cdd:cd06905    48 -------------NGETG----PADEKPA---LWVDGNIHGNEVTGSEVALYLAEYLLTNY 88
CarbopepD_reg_2 pfam13715
CarboxypepD_reg-like domain; This domain family is found in bacteria, archaea and eukaryotes, ...
463-538 4.47e-06

CarboxypepD_reg-like domain; This domain family is found in bacteria, archaea and eukaryotes, and is approximately 90 amino acids in length. The family is found in association with pfam07715 and pfam00593.


Pssm-ID: 433425 [Multi-domain]  Cd Length: 88  Bit Score: 44.89  E-value: 4.47e-06
                          10        20        30        40        50        60        70
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1215457371 463 VKGFVKDL-QGNPIANATISVEGISHDITSAKDGDY-WRLLVPGNYKLTASAPGYLAITKKVAVPFSPAVVVDFELES 538
Cdd:pfam13715   1 ISGTVVDEnTGEPLPGATVYVKGTTKGTVTDADGNFeLKNLPAGTYTLVVSFVGYKTQEKKVTVSNDNTLDVNFLLKE 78
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH